Gene expression profile for schizophrenia: Discrete neuron transcription patterns in the entorhinal cortex

Archives of General Psychiatry

Volumn 59, Issue 7, 2002, Pages 631-640

  Hemby, Scott E ^a   Ginsberg, Stephen D ^b   Brunk, Brian ^c   Arnold, Steven E ^c   Trojanowski, John Q ^c   Eberwine, James H ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SYNAPTOPHYSIN;

AGED; ANALYSIS OF VARIANCE; ARTICLE; AUTOPSY; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENTORHINAL CORTEX; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; NERVE CELL; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; STELLATE CELL; TEMPORAL LOBE;

EID: 0036307210     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.59.7.631     Document Type: Article

References (71)

1. Functional brain-imaging studies in schizophrenia
2. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia
3. Brain morphology and schizophrenia: A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures
4. Abnormalities of the left temporal lobe and thought disorder in schizophrenia: A quantitative magnetic resonance imaging study
5. An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia
6. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia
7. MRI findings in medial temporal lobe structures in schizophrenia
8. Magnetic resonance imaging findings of amygdala-anterior hippocampus shrinkage in male patients with schizophrenia
9. Temporolimbic volume reductions in schizophrenia
10. Effects of diagnosis, laterality, and gender on brain morphology in schizophrenia
11. Structural abnormalities in deficit and nondeficit schizophrenia
12. Frontal and temporal lobe brain volumes in schizophrenia: Relationship to symptomatology and clinical subtype
13. Sex differences in neuropsychological functioning of first-episode and chronically ill schizophrenic patients
14. No evidence for astrogliosis in brains of schizophrenic patients: A post-mortem study
15. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia
16. In pursuit of the molecular neuropathology of schizophrenia
17. Detection and quantification of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed, paraffin wax-embedded sections
18. Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia
19. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography
20. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia
21. Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia
22. Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients
23. SNAP-25 deficit and hippocampal connectivity in schizophrenia
24. The catecholaminergic innervation of the human entorhinal cortex: Alterations in schizophrenia
25. Increased density of entorhinal glutamate-immunoreactive vertical fibers in schizophrenia
26. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia
27. Further evidence of cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia using spatial point pattern analyses
28. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia
29. Prenatal developmental disturbances in the limbic allocortex in schizophrenics
30. Smaller neuron size in schizophrenia in hippocampal subfields that mediate corticalhippocampal interactions
31. Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia
32. Entorhinal-hippocampal connections: A speculative view of their function
33. Molecular analysis of the single cell: Importance in the study of psychiatric disorders
34. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex
35. Prospective clinicopathologic studies of schizophrenia: Accrual and assessment of patients
36. Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques
37. A comparative study of quantitative stains for DNA in image cytometry
38. Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats
39. In situ transcription: Specific synthesis of cDNA in fixed tissue sections
40. Amplified RNA synthesized from limited quantities of heterogeneous cDNA
41. Analysis of gene expression in single live neurons
42. Expression profile of transcripts in Alzheimer's disease tangle bearing CA1 neurons
43. Gene expression and neuronal activity in schizophrenia: A study of polyadenylated mRNA in the hippocampal formation and cerebral cortex
44. Distribution of beta-adrenergic receptor subtypes in human postmortem brain: Alterations in limbic regions of schizophrenics
45. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: Effects of schizophrenia
46. AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics
47. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains
48. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: Evidence on reversible up-regulation by typical neuroleptics
49. Glutamate receptor expression in schizophrenic brain
50. Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects
51. Differences in the subregional and cellular distribution of GABAA receptor binding in the hippocampal formation of schizophrenic brain
52. Changes in serotonin2A and GABA(A) receptors in schizophrenia: Studies on the human dorsolateral prefrontal cortex
53. Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: Focus on GABA content, GABA(A) receptoralpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression
54. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia
55. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
56. The synaptic vesicle cycle: A cascade of protein-protein interactions
57. 2+-dependent electrostatic switch
58. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia
59. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: A possible neurochemical basis for "hypofrontality"
60. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia
61. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia: Regional and diagnostic specificity
62. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia
63. Effect of chronic haloperidol treatment on synaptic protein mRNAs in the rat brain
64. Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes
65. Isotype-specific G protein abnormalities in the left superior temporal cortex and limbic structures of patients with chronic schizophrenia
66. NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia
67. Characterization of the human and rat phospholemman (PLM) cDNAs and localization of the human PLM gene to chromosome 19q13.1
68. Unitary anion currents through phospholemman channel molecules
69. Structural domains in phospholemman: A possible role for the carboxyl terminus in channel inactivation